Can B Corp.’s (OTCQB: CANB) Stanley Teeple, Director And CFO, Discusses Company’s Competitive Advantage, Product Diversification And Medical Impact Of Its CBD Products On The Stock Market Podcast
Can B Corp.’s (OTCQB: CANB) released today (October 29, 2020) an interview with Director and CFO, Stanley Teeple, on The Stock Market Podcast for an interview. He discussed with host Jane King the company’s competitive advantage, seed-to-sale strategy, brand marketing, the impact of CBD and the firm’s important Medical Advisory Board. He also explained the effectiveness of the company’s Duramed Division’s Sustained Acoustic Medicine (SAM) Pro 2.0 Ultrasound Program FDA-approved medical device which is designed to accelerate tissue healing and reduce chronic pain. Can B Corp. (OTCQB: CANB) recently announced that SAM Pro 2.0 has expanded to the whole state of Michigan — in addition to its existing availability in New York and New Jersey. Hear the interview on The Stock Market Podcast.
The CBD market has drawn intense interest from media companies. stockmarketpress.com features specialized coverage of related stocks such as Can B Corp. (OTCQB: CANB), Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Cronos Group (NASDAQ: CRON), Canopy Growth Corp. (NYSE: CGC), Charlotte’s Web (CSE: CWBHF), INSYS Therapeutics, Inc. (NASDAQ: INSY), cbdMD (NYSE: YCBD), Joy Organics (NASDAQ: JOYG),, GW Pharmaceuticals (NASDAQ: GWPH) and Supreme Cannabis Co. (OTC: SPRWF).
Can B Corp.’s (OTCQB: CANB) Stanley Teeple, Director And CFO, Discusses Company’s Competitive Advantage, Product Diversification And Medical Impact Of Its CBD Products On The Stock Market Podcast
Stanley Teeple, Director and CFO, said, “We are presently a vertically integrated CBD seed-to-sale company,” and described the importance of growing its own plants, controlling all quality-control which can produce isolate and distillate from Can B’s (OTCQB: CANB) own grown and processed hemp plants. From its GMP compliant facility in Lacey, Washington, it can process the product. Teeple added, “This is a point of differentiation, proprietary processing. Most of our competitors don’t do it.” He noted that after the passage of the Federal Farm Bill of 2018, all of Can B’s (OTCQB: CANB) product is federally legal in all 50 states. The company’s products do not contain any hallucinogenic THC, he said, explaining that his company is in the health and wellness business, instead. Can B Corp.’s (OTCQB: CANB) Stanley Teeple, Director And CFO, Discusses Company’s Competitive Advantage, Product Diversification And Medical Impact Of Its CBD Products On The Stock Market Podcast.
SAM Pro 2.0 Ultrasound Program Available Now In State Of Michigan, In Addition To New York And New Jersey
Teeple said he is especially proud of the firm’s Duramed Division and its SAM Pro 2.0 Ultrasound Program and its FDA-approved ultrasound device. At the compact size of a cell phone, he said, this device speeds recovery for chronic pain and accelerates tissue healing. Can B (OTCQB: CANB) recently announced that SAM Pro 2.0 availability has now been expanded to the whole state of Michigan, in addition to current availability in New York and New Jersey.
Role Of Can B’s (OTCQB: CANB) Medical Advisory Board
Teeple, CFO and Director of the Company, discussed the three operating divisions of the company and the impact of its Medical Advisory Board. He discussed the role of Marco Alfonsi, CEO of Can B (OTCQB: CANB), in overseeing the structure of the Company, its subsidiaries and its new product development program. Teeple said the Company’s products are targeted to a diverse mix of medical offices (professional market, physicians), online to consumers, in greater than 1,000 retail locations plus the pet market. One growth brand Teeple singled out is Can B SuperFoods. Can B Corp.’s (OTCQB: CANB) Stanley Teeple, Director And CFO, Discusses Company’s Competitive Advantage, Product Diversification And Medical Impact Of Its CBD Products On The Stock Market Podcast.
“CBD Products Really Work”
Medical professionals on the company’s Medical Advisory Board have seen the performance of Can B (OTCQB: CANB) products, Teeple said. “CBD products really work.” These physicians are interested in weaning their patients off opioid products. In its effort to promote health and wellness for its customers, the Company’s now markets Can B Super Foods, a line of natural whole foods products that includes smoothies and brownies — and offers more naturally healthy food, he said. Can B Corp.’s (OTCQB: CANB) Stanley Teeple, Director And CFO, Discusses Company’s Competitive Advantage, Product Diversification And Medical Impact Of Its CBD Products On The Stock Market Podcast.
To learn more about the company, go to its website at https://www.canbcorp.com/about-us/
Can B Corp. (OTCQB: CANB) is a health and wellness company providing CBD products under the brands Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. It markets to multi-channels including medical offices, doctor’s offices, retailers, online and direct.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Contact:
Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press
